Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCIN-C: Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C
NCT00624325Phase 3Completed
- Sponsor
- Foundation for Liver Research
- Start
- Jul 2007
- Primary completion
- Jun 2010
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon alfa-2b in hepatitis C (HCV), sponsored by Foundation for Liver Research. Started Jul 2007; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00624325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00624325.